Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...

Please provide your email address to receive an email when new articles are posted on . The campaign follows the approval of Xolair for the reduction of allergic reactions after accidental exposure.

Omalizumab is indicated for the treatment of persistent asthma, chronic rhinosinusitis with nasal polyps, food allergies and ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study, which ...

LA CROSSE, Wis. (WEAU) - The drug Xolair has been available for more than 20 years, and while it’s is normally used to treat asthma, a recent study lead the FDA to approve it to help those with food ...

Local Team USA figure skater Brendan Mullen has always had to pack his own food for international competitions. Mullen has several food allergies to eggs, tree nuts and peanuts. With a bag full of ...

Kashiv BioSciences has reported encouraging topline outcomes from the randomised confirmatory trial of the proposed biosimilar to Novartis’ Xolair (omalizumab), ADL-018. The multicentre, double-blind ...

LONDON (Reuters) - Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should ...

Amneal submits a BLA for a new Xolair biosimilar, promising affordable treatment options for asthma and allergies, enhancing ...